Synthego

Jun 26, 2025

Synthego Gains Approval to Proceed with Sale to Perceptive Advisors; Transaction Set to Close in July

Apr 08, 2025

Synthego and Vita Therapeutics Announce Strategic Licensing Agreement for hfCas12Max CRISPR Nuclease

Mar 27, 2024

Synthego Announces CEO Transition to Focus on Enabling CRISPR Therapeutics

Mar 27, 2024

Synthego Announces CEO Transition to Focus on Enabling CRISPR Therapeutics

Mar 27, 2024

EditCo Bio and Telegraph Hill Partners Acquire Synthego's Engineered Cell Solutions Business to Enable Cellular Research

Mar 27, 2024

EditCo Bio and Telegraph Hill Partners Acquire Synthego's Engineered Cell Solutions Business to Enable Cellular Research

Jan 23, 2024

Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers

Oct 15, 2020

Synthego's CRISPR Platform Enables Faster Identification of Potential Coronavirus Treatment

Aug 26, 2020

Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand